Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 6/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | PAM | P19021 | 2/20 | 0.55 |
| ▸ | CES2 | O00748 | 3/20 | 0.54 |
| ▸ | CES1 | P23141 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | PPARG | P37231 | 6/20 | 0.52 |
| ▸ | PPARD | Q03181 | 6/20 | 0.52 |
| ▸ | PPARA | Q07869 | 6/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.52 |
| ▸ | TLR2 | O60603 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | FABP4 | P15090 | 2/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.52 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.52 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9844549 | 1.00 | DGKA (0.61) | DGKALMNATSHRALDH1A1PAM | |
| SCHEMBL177409 | 1.00 | DGKA (0.61) | DGKALMNATSHRALDH1A1PAM | |
| SCHEMBL7647987 | 1.00 | DGKA (0.61) | DGKALMNATSHRALDH1A1PAM | |
| SCHEMBL10642835 | 1.00 | DGKA (0.61) | DGKALMNATSHRALDH1A1PAM | |
| SCHEMBL539005 | 1.00 | DGKA (0.61) | DGKALMNATSHRALDH1A1PAM | |
| SCHEMBL926254 | 1.00 | DGKA (0.61) | DGKALMNATSHRALDH1A1PAM | |
| SCHEMBL4152672 | 1.00 | DGKA (0.61) | DGKALMNATSHRALDH1A1PAM | |
| SCHEMBL2189614 | 1.00 | DGKA (0.61) | DGKALMNATSHRALDH1A1PAM | |
| SCHEMBL2029048 | 1.00 | DGKA (0.61) | DGKALMNATSHRALDH1A1PAM | |
| SCHEMBL2222481 | 1.00 | DGKA (0.61) | DGKALMNATSHRALDH1A1PAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022520-A1 | METHOD FOR ACYLATING A HYDROXYLATED SOLID MATERIAL | CELLULOTECH INC (CA) | 2026-01-22 | — | — | US | claimed |
| EP-4466401-A1 | METHOD FOR ACYLATING A HYDROXYLATED SOLID MATERIAL | Cellulotech Inc. (CA) | 2024-11-27 | — | — | EP | claimed |
| WO-2023233202-A1 | METHOD FOR ACYLATING A HYDROXYLATED SOLID MATERIAL | CELLULOTECH INC (CA) | 2023-12-07 | — | — | WO | claimed |
| CN-111485450-A | Preparation method of high-melting-point AKD sizing agent | 济宁明升新材料有限公司 | 2020-08-04 | — | — | CN | claimed |
| US-4272502-A | Process for preparing gaseous hydrogen chloride from dilute aqueous hydrochloric acid | CHEMISCHE WERKE HULS AKTIENGESELLSCHAFT (DE) | 1981-06-09 | — | — | US | claimed |
| US-20260022520-A1 | METHOD FOR ACYLATING A HYDROXYLATED SOLID MATERIAL | CELLULOTECH INC (CA) | 2026-01-22 | — | — | US | disclosed |
| EP-4466401-A1 | METHOD FOR ACYLATING A HYDROXYLATED SOLID MATERIAL | Cellulotech Inc. (CA) | 2024-11-27 | — | — | EP | disclosed |
| US-20240343956-A1 | TACKY AGENT-FORMING COMPOSITION AND PRODUCTION METHOD THEREOF, AND TACKY AGENT COMPOSITION | DEXERIALS CORPORATION (JP) | 2024-10-17 | — | — | US | disclosed |
| WO-2023233202-A1 | METHOD FOR ACYLATING A HYDROXYLATED SOLID MATERIAL | CELLULOTECH INC (CA) | 2023-12-07 | — | — | WO | disclosed |
| WO-2023021975-A1 | COMPOSITION FOR FORMING PRESSURE-SENSITIVE ADHESIVE, PRODUCTION METHOD THEREFOR, AND PRESSURE-SENSITIVE ADHESIVE COMPOSITION | デクセリアルズ株式会社 | 2023-02-23 | — | — | WO | disclosed |
| WO-2021140480-A1 | METHOD FOR THE PREPARATION OF ARAMCHOL | ICE S.P.A. (IT) | 2021-07-15 | — | — | WO | disclosed |
| CN-111548272-B | Self-thickening surfactant and preparation method thereof | 江南大学 | 2021-04-06 | — | — | CN | disclosed |
| CN-111485450-A | Preparation method of high-melting-point AKD sizing agent | 济宁明升新材料有限公司 | 2020-08-04 | — | — | CN | disclosed |
| CN-110981933-A | Method for efficiently synthesizing Aramchol | 合肥工业大学 | 2020-04-10 | — | — | CN | disclosed |
| CN-106167506-A | A kind of oil-soluble molybdenum amine complex and preparation method thereof | 西北有色金属研究院 | 2016-11-30 | — | — | CN | disclosed |
| CN-102015903-B | Use of a (1-3)-beta-D-glucan as an emulsion stabiliser | SHANXI XIYUEFA ROAD AND BRIDGE BUILDING MATERIALS CO LTD | 2014-06-25 | — | — | CN | disclosed |
| CN-102015903-A | Use of a (1-3)-beta-D-glucan as an emulsion stabiliser | LATEXFALT BV | 2011-04-13 | — | — | CN | disclosed |
| US-20030152602-A1 | Cyclodextrins preferentially substituted on their primary face by acid or amine functions | COLETICA (FR) | 2003-08-14 | — | — | US | disclosed |
| US-6524595-B1 | Dermopharmaceuticals. | COLETICA (FR) | 2003-02-25 | — | — | US | disclosed |
| US-4272502-A | Process for preparing gaseous hydrogen chloride from dilute aqueous hydrochloric acid | CHEMISCHE WERKE HULS AKTIENGESELLSCHAFT (DE) | 1981-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030152602-A1 | Cyclodextrins preferentially substituted on their primary face by acid or amine functions | NR5A1, NR4A2, ADIPOR1 | DGKA 1651/4885LMNA 3108/4885TSHR 541/4885 |
| US-20260022520-A1 | METHOD FOR ACYLATING A HYDROXYLATED SOLID MATERIAL | ELOVL3, ELOVL1, ACSL1 | DGKA 875/4885LMNA 2869/4885TSHR 3342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.